Home / Search

Search

21 Search Results

Efficiency and safety of direct acting antivirals in chronic hepatitis C patients ınfected with genotype 2 and 3 in Turkey

Behice Kurtaran, Figen Sarıgül, Mehmet Çabalak, Sibel Kaya, Nagehan Didem Sarı, Hasan Karsen, Esra Zerdali, Rahmet Güner, Kamuran Türker, Nevin Ince, Fehmi Tabak, Hepcturkey Study Group
Full Text PDF
DOI Link

Efficacy and safety of Paritaprevir/Ritonavir + Ombitasvir ± Dasabuvir ± Ribavirin in chronic hepatitis C patients with chronic renal failure

Fatih Güzelbulut, Ekrem Aslan, Ayça Gökçen Değirmenci Saltürk, Özgür Bahadır, Halil Şahin, Mevlüt Kiyak, Emine Kanatsız, Mustafa Keçeci
Full Text PDF
DOI Link

Real-world efficacy, safety and clinical outcomes of ombitasvir/ paritaprevir/ ritonavir ± dasabuvir ± ribavirin combination therapy in patients with hepatitis C virus genotype 1 or 4 infection: Turkey experience

Bilgehan Aygen, Neşe Demirtürk, Orhan Yıldız, Mustafa Kemal Çelen, Ilhami Çelik, Şener Barut, Onur Ural, Ayşe Batırel, Reşit Mıstık, Funda Şimşek, Ali Asan, Gülden Ersöz, Nesrin Türker, Hüseyin Bilgin, Çiğdem Ataman Hatipoğlu, Faruk Karakeçili, A A
Full Text PDF
DOI Link

Awareness of hepatitis C

Ömer Öztürk, Ilyas Tenlik, Derya Arı, Hale Gökcan, Sabite Kaçar, Meral Akdoğan
Full Text PDF
DOI Link

Real-world efficacy, safety, and clinical outcomes of ombitasvir/paritaprevir/ritonavir ± dasabuvir ± ribavirin combination therapy in patients with hepatitis C virus genotype 1 or 4 infection: The Turkey experience experience

Bilgehan Aygen, Neşe Demirtürk, Orhan Yıldız, Mustafa Kemal Çelen, İlhami Çelik, Şener Barut, Onur Ural, Ayşe Batırel, Reşit Mıstık, Funda Şimşek, Ali Asan, Gülden Ersöz, Nesrin Türker, Hüseyin Bilgin, Sami Kınıklı, Faruk Karakeçili, Gökmen Zararsız
Full Text PDF
DOI Link

Positive effect of single nucleotide RAD51 135G>C polymorphism and low Ku70 protein expression on female rectal cancer patients survival after preoperative radiotherapy

Anna Gasinska, Beata Biesaga, Anna Janecka Widla, Zbigniew Darasz
Full Text PDF
DOI Link

Real-Life Experience of Hepatitis C Treatment with Direct-Acting Antivirals in Genotypes 2 and 3

Sibel Yıldız Kaya, Behice Kurtaran, Nefise Öztoprak Çuvalcı, Yusuf Önlen, Mehmet Reşat Ceylan, Esra Zerdali, Nagehan Didem Sarı, Ahsen Öncül, Nurettin Erben, Ayse Batirel, Dilara İnan, Süheyla Kömür, Figen Sarıgül Yıldırım, Hasibullah Yaqoobi, Ferit Kuscu, Rahmet Guner, Fehmi Tabak, Hep-C Türkiye Study Group
Full Text PDF
DOI Link

Sustained viral response to new HCV treatment (direct-acting antivirals) in the second year of treatment and evaluation of side effects

Seher Ayten Coskuner, Selma Tosun
Full Text PDF
DOI Link

A real-life evaluation of the effect of direct-acting antivirals in hemodialysis patients with chronic hepatitis C

Nurten Nur Aydın, Firdevs Aksoy, Ilknur Yavuz, Serap Iskender, Arzu Altuncekic Yildirim, Ilknur Esen Yıldız, Iftihar Koksal
Full Text PDF
DOI Link

Investigation of the factors affecting the response of treatment ın patients treated with oral direct acting antiviral agents

Yucel Ustundag, Yonca Yilmaz Urun, Aydin Seref Koksal, Oguz Karabay, Bilal Toka, Ahmet Tarik Eminler, Ertugrul Guclu, Erkan Parlak
Full Text PDF
DOI Link

Real-life results of treatment with ombitasvir, paritaprevir, dasabuvir, and ritonavir combination in patients with chronic renal failure infected with HCV in Turkey

Serkan Yaraş, Enver Üçbilek, Osman Özdoğan, Fehmi Ateş, Engin Altıntaş, Orhan Sezgin
Full Text PDF
DOI Link

Clinical outcomes after cessation of potent antiviral treatment in chronic hepatitis B patients

Fatma Tuğçe Şah, Onur Keskin, Fatih Karakaya, Zeynep Ellik, Aysun Çalışkan Kartal, Esra Yurdcu, Mithat Bozdayı, Ramazan Idilman, Cihan Yurdaydın
Full Text PDF
DOI Link

Daclatasvir plus sofosbuvir regimen sheds promising light on future hepatitis C virus genotype 3 therapies

Ali Murat Kahveci, Veysel Tahan
Full Text PDF
DOI Link

The Relationship between Gastroduodenal Pathologies and Helicobacter pylori cagL (Cytotoxin-Associated Gene L) Polymorphism

Doğukan Özbey, Süleyman Demiryas, Seher Akkuş, Nuray Kepil, Harika Öykü Dinç, Nesrin Gareayaghi, Mehmet Demirci, Enes Ali Kurt, Ömer Uysal, Suat Sarıbaş, Hrisi Bahar Tokman, Bekir Kocazeybek
Full Text PDF
DOI Link

Successfully treatment of chronic hepatitis C with direct-acting antiviral agents: a single center experience

Aysun Kartal, Dilara Turan Gökçe, Mesut Gümüşsoy, Mehmet Berk Örüncü, Necati Örmeci, Cihan Yurdaydın, Hasan Özkan, Ramazan Idilman
Full Text PDF
DOI Link

Development of hypocalcemia with telaprevir-based triple treatment in a case of genotype 1 chronic hepatitis C

Ebubekir Şenateş, Yaşar Çolak, Atakan Yeşil, İlyas Tuncer
Full Text PDF
DOI Link

A case with chronic HBV infection who was non-responder to nucleos(t)ide analogues was treated with Pegylated interferon

Figen Sarigül Yildirim, Murat Sayan, Murat Sayan, Derya Seyman, Ozlem Elpek
Full Text PDF
DOI Link

Toll-like receptor 2 and 4 polymorphisms associated with Helicobacter pylori susceptibility and gastric cancer

Taweesak Tongtawee, Theeraya Simawaranon, Wareeporn Wattanawongdon, Chavaboon Dechsukhum, Wilairat Leeanansaksiri
Full Text PDF
DOI Link

Direct-acting antiviral drugs used ın the treatment of HCV Increase cholesterol levels

Osman Ozdogan, Serkan Yaras, Enver Ucbilek, Fehmi Ates, Orhan Sezgin, Engin Altintas
Full Text PDF
DOI Link

Efficiency and safety of direct-acting antiviral in cirrhotic hepatitis C infection patients: Real-life data from Turkey

Yeşim Taşova, Tansu Yamazhan, Şaban Esen, Nefise Çuvalcı Öztoprak, Yusuf Önlen, Nagehan Didem Sarı, İlknur Esen Yıldız, Dilara İnan, Esra Zerdali, Rahmet Güner, Şener Barut, Hayat Kumbasar Karaosmanoğlu, Sibel Kaya, Nevin İnce, İlyas Dökmetaş, Fehmi Tabak, Hepcturkey Study Group
Full Text PDF
DOI Link

Transcriptome-Wide Association Study of Metabolic Dysfunction-Associated Steatotic Liver Disease Identifies Relevant Gene Signatures

Jianxiu Wang, Qian Gao
DOI Link
1 - 21 of 21 items